Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Network Grenada.
Press releases published on September 11, 2025
Eightfold AI Appoints Amber Grewal as Chief Growth Officer
SANTA CLARA, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Eightfold AI, the leader in AI-powered talent intelligence, today announced the appointment of Amber Grewal as Chief Growth Officer. She will report to Co-founder and CEO Ashutosh Garg, and will be …
KPA Announces Michael Bruns as Chief Executive Officer
WESTMINSTER, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- KPA, a leading provider of environment, health, and safety and workplace compliance solutions, today announced the appointment of Michael Bruns as Chief Executive Officer. Bruns brings more than 30 …
Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance
RA'ANANA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced pivotal …
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today highlighted positive efficacy …
24/7 Market News: TEN Holdings Powers Up with SaaS Pivot
DENVER, Sept. 11, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that TEN Holdings (NASDAQ: XHLD), a provider of event planning, …
Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors
– Dr. Chang led XOLAIR® from invention through FDA approval and commercialization, exceeding $5 billion in sales so far – Los Angeles, CA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Company”, “We” or “Us”), a clinical-stage …
NETSOL Technologies secures landmark multi-million-dollar contract with leading Australian auto captive of Japanese origin
ENCINO, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a leader in AI-powered solutions and services enabling OEMs, dealerships and financial institutions to sell, finance and lease assets, has announced the signing of …
Lucas GC Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Compliance
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence (the “AI”) technology-driven Platform-as-a-Service (the “PaaS”) company whose technologies have been applied to the human …
MKS Inc. Releases 2025 Environmental, Social, Governance Report
ANDOVER, Mass., Sept. 11, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today released its 2025 Environmental, Social, Governance (ESG) Report, which highlights MKS’ continued …
Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
NPI-001 shows more than 50% reduction in photoreceptor loss caused by RP associated with USH over two years NPI-001 was well tolerated, with no persistent drug-related adverse events Results were leveraged to design confirmatory trial planned for 2026 FORT …
New Engen Earns Spot on ADWEEK’s Fastest Growing Agencies List for Third Consecutive Year, Ranking Among Top Five Large Agencies in 2025
SEATTLE, Sept. 11, 2025 (GLOBE NEWSWIRE) -- New Engen, a leading digital marketing agency, today announced its recognition on the 2025 ADWEEK Fastest Growing Agencies list for the third consecutive year, ranking among the top five large agencies this year. …
Longer-Term Forecasts for Litecoin are More Optimistic with Bullish Expectations Suggested
PALM BEACH, Fla., Sept. 11, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Numerous crypto news industry insiders are bullish for Litecoin this year and through 2031. One such observer said: “The crypto market is entering a new chapter where …
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available treatments for IPF are limited to only two approved drugs …
Shoals Technologies Group Secures a New Patent for BLA Architecture, Reinforcing American Intellectual Property
PORTLAND, Tenn., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Shoals) (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today the issuance of its new U.S. …
FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment
HOUSTON, Sept. 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium
MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that the company will present four …
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th
MOUNTAIN VIEW, Calif., Sept. 11, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug- …
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP) Breadth of the data across Phase 2 program to be discussed at Arrowhead’s 19th Annual Pain Summit THE …